Literature DB >> 20456559

Analysis of plasma D-dimer concentration in patients with delayed pressure urticaria.

A Kasperska-Zając1, T Jasinska.   

Abstract

BACKGROUND: Activation of fibrinolysis system has been observed in spontaneous urticaria. AIM: To investigate the haemostatic activation in DPU, expressed by plasma D-dimer concentration, the index of active fibrinolysis.
METHODS: Plasma D-dimer concentrations were measured in eight patients with pure DPU of varying severity as well as in 30 healthy subjects.
RESULTS: The analysis of individual results indicated that three patients of the eight show d-dimer concentration higher than the upper limit of the normal range. All the patients had severe DPU and manifested extensive lesions. The remaining five milder cases showed values within the normal range.
CONCLUSIONS: Our analysis revealed that DPU patients may differ in their haemostatic activation state depending on severity of the disease. In severe DPU cases hyperfibrinolysis may occur, manifested by elevated plasma d-dimer concentration, probably as a consequence of the systemic inflammatory response.
© 2010 The Authors. Journal of the European Academy of Dermatology and Venereology © 2010 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20456559     DOI: 10.1111/j.1468-3083.2010.03699.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  2 in total

1.  Chronic spontaneous urticaria: a low-grade disseminated intravascular coagulation only partially reversed by Omalizumab.

Authors:  Marina Di Pino; Maria Filomena Ruberto; Giulia Costanzo; Davide Firinu; Maria Sebastiana Piras; Mario Nicola Mura; Stefano Del Giacco; Ferdinando Coghe; Francesco Marongiu; Doris Barcellona
Journal:  Clin Exp Med       Date:  2022-05-25       Impact factor: 5.057

2.  Analysis of procalcitonin and CRP concentrations in serum of patients with chronic spontaneous urticaria.

Authors:  A Kasperska-Zajac; A Grzanka; E Machura; B Mazur; M Misiolek; E Czecior; J Kasperski; J Jochem
Journal:  Inflamm Res       Date:  2012-12-04       Impact factor: 4.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.